Speaker Series - Endocrine resistance in metastatic breast cancer

In this Review:

Management of endocrine resistance:
The science behind the studies
Professor Stephen Johnston (UK)
Current endocrine strategies in
metastatic breast cancer: Advantages
and practical limitations
Professor Arlene Chan (Australia)
DEBATE: Targeted therapies and endocrine
treatments should be combined
upfront before endocrine resistance
can develop
YES: Dr Javier Cortes (Spain)
NO: Professor Stephen Johnston (UK)

Please login below to download this issue (PDF)